Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2024-01-22 Board/Management Inform…
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Expansion of leadership team
Board/Management Information Classification · 100% confidence The document is an official announcement released via RNS (RNS Number : 3756A) on January 22, 2024. The core content announces the 'Expansion of leadership team,' specifically the appointment of a new Chief Financial Officer (CFO) and the transition of the previous CFO to Chief Operating Officer (COO). This directly relates to changes in senior management personnel. According to the definitions, 'Board/Management Information' (Code: MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' Although it is distributed via RNS, the specific subject matter is MANG, which takes precedence over the general regulatory filing fallback.
2024-01-22 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by Persons Discharging Managerial Responsibilities (PDMRs), specifically Tim Cowper and Clive Brown of Oxford Nanopore Technologies plc. It details the purchase of partnership shares and the grant of matching shares under a Share Incentive Plan (SIP). This type of disclosure is a standard regulatory requirement for insider dealings, which falls under the 'Director's Dealing' category.
2024-01-11 English
Employee Stock Purchase Plan - PDMR Notification
Director's Dealing Classification · 100% confidence The document is an official notification released via RNS (RNS Number : 4495Z) on January 11, 2024. It details a transaction involving the issuance of shares to a director (James Willcocks, a PDMR) under an Employee Stock Purchase Plan (ESPP). This type of transaction report, specifically detailing personal share transactions by directors/executives, falls under the category of Director's Dealing (DIRS). Although it mentions RNS and is distributed by RNS, the core content is the insider transaction disclosure, making DIRS more specific than the general RNS fallback.
2024-01-11 English
FY23 trading update
Earnings Release Classification · 100% confidence The document is titled 'FY23 trading update' and provides preliminary financial performance figures (LSRT revenue, gross margin expectations) for the fiscal year ended December 31, 2023, ahead of the full results release on March 6th. This structure—a preliminary announcement of key financial highlights before the comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but rather the initial disclosure of period results. The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the content specifically points to an earnings update. FY 2023
2024-01-09 English
Presentation at 42nd Annual J.P. Morgan Conference
Report Publication Announcement Classification · 99% confidence The document is a short announcement disseminated via RNS (RNS Number: 4256Y) on January 3, 2024. The content explicitly states that Oxford Nanopore Technologies plc will 'Present at 42nd Annual J.P. Morgan Healthcare Conference' on January 9, 2024, and provides webcast details. This is not a full report (like 10-K or IR), nor is it a formal AGM presentation material (AGM-R). It is an announcement about participation in an external industry conference, which is a general regulatory disclosure. Given the options, the most appropriate classification for a general, non-standard regulatory announcement distributed via RNS, especially one detailing participation in an external event, is the fallback category, Regulatory Filings (RNS). The document length (3398 chars) also supports the 'announcement' nature rather than a full report.
2024-01-03 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement disseminated via RNS (RNS Number: 4121Y) from Oxford Nanopore Technologies plc, dated January 2, 2024. The content explicitly details the 'Issue of Equity' (issuance of 337,374 ordinary shares following option exercises) and provides the 'Total Voting Rights' as of December 31, 2023, referencing FCA Disclosure Guidance and Transparency Rule 5.6.1. This type of announcement, which reports on share issuance and updates the total voting rights denominator, directly relates to capital structure changes and share movements. While it involves share issuance (suggesting SHA), the primary focus and structure align perfectly with reporting changes in the number of shares outstanding and voting rights, which is often categorized under general regulatory updates or specific share actions. Given the options, 'Share Issue/Capital Change' (SHA) is highly relevant due to the explicit mention of share issuance. However, the document also serves as a mandatory regulatory disclosure regarding the total number of voting rights, which is a specific type of regulatory filing. Since the core action is the issuance of shares and the resulting change in capital structure, SHA is the most precise fit among the specific codes, although RNS is also applicable as a general regulatory announcement. I will classify it as SHA because the primary event being reported is the issuance of new shares and the resulting capital structure update.
2024-01-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.